Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis - Wikidata - awgldk - TriplyDB

Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis

Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis

http://www.wikidata.org/entity/Q24545775

about

Beta-blockers for hypertension Time course for blood pressure lowering of dual alpha and beta blockers Beta-blockers for hypertension Beta-blockers for hypertension Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies What is an appropriate blood pressure goal for the elderly: review of recent studies and practical recommendations Beta-blockers for hypertension.Treatment of hypertension in obese patients.Laboratory testing in newly treated elderly hypertensive patients without co-morbidities: a population-based cohort study Relation of beta-blocker use with frequency of hospitalization for heart failure in patients with left ventricular diastolic dysfunction (from the Heart and Soul Study)White coat effect and white coat hypertension: one and the same?Prescribing of Antihypertensive Agents in Public Primary Care Clinics - is it in Accordance with Current Evidence?Review of nifedipine GITS in the treatment of high risk patients with coronary artery disease and hypertension Hypertension in the elderly: Are we all on the same wavelength?When not to use beta-blockers in seniors with hypertension Coronary artery disease in Africa and the Middle East.Beta blockers in hypertension and cardiovascular disease.Rebuttal: Do beta-blockers have a role in treating hypertension? Yes Rebuttal: Do beta-blockers have a role in treating hypertension? No Do beta-blockers have a role in treating hypertension? Yes.Do beta-blockers have a role in treating hypertension? No Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial The current management of carotid atherosclerotic disease: who, when and how?Valsartan/hydrochlorothiazide: a review of its use in the management of hypertension.The vasodilatory beta-blockers.Polytherapy with two or more antihypertensive drugs to lower blood pressure in elderly Ontarians. Room for improvement.Pulse pressure and adverse outcomes in women: a report from the Women's Ischemia Syndrome Evaluation (WISE)Hypertension treatment in the Asia-Pacific: the role of and treatment strategies with nebivolol Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patients.Jnc 7.5.Beta-blockers: no longer an option for uncomplicated hypertension.Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes.Antihypertensive medications and their effects on lipid metabolism.Management of hypertension in the elderly patient.Integration of evidence based medicine into a medical curriculum Management of hypertension in chronic heart failure.Now or never: optimal antihypertensive therapy in the elderly.β-Blockers are associated with a reduction in COPD exacerbations.Beta-blockers in the treatment of hypertension: are there clinically relevant differences?

P2860

Q24201511-792E0CCB-FE49-4029-93FC-F5DFE53665C3 Q24201866-83D8AD9E-2184-4122-9A49-991E3753A837 Q24202812-91F21937-3E22-4277-8F58-76FF95DECF1E Q24243099-B75FCCF2-4E59-4AE5-9010-1EF7DCEC4CDC Q24658205-81F834FF-5E51-4780-8C88-6EBD0B07D82F Q26864349-04B0D060-5BEE-4D87-BEB1-CA5EE19761BA Q30238911-22B9C207-88F1-4FED-B26B-9257417029ED Q30429298-F772EF50-4C36-4437-BEB8-EC92F793E6E9 Q33572877-7A177B5E-C41B-40AF-B57D-5BDAB663D47A Q33682749-338083C0-368A-4BF7-8DCA-158B00A96631 Q34220625-F6A16658-52FD-40EF-9893-654D8EE6C93C Q34220716-DCC5526A-1470-481F-85E9-1EB44744CC90 Q34983445-713097FA-C41B-4149-BB62-53D83C2F3FB5 Q35185094-CF00E705-7399-432C-8B93-1F0723DADA9C Q35246527-05CF0F86-AD35-4221-AA6E-C2FD985520D2 Q35771356-DFD44620-BF78-4675-947A-7BD45BBF8DDD Q35782957-9E1A8938-F70D-4B48-BEFC-7F49ECA6745C Q35941880-8B66045B-CF95-4426-90DC-5E43A43EF5BE Q35941885-DA10CE73-6414-421D-9FFD-86AD77975006 Q35951348-8A43A695-E275-4D4E-A488-E20450BB8B23 Q35951354-E379F26B-C018-4C5B-A739-0BDE3141588B Q36156527-CD489A06-0EBF-48CC-930A-6E567AB2292F Q36599659-9AECFB6F-27D7-4912-AFF2-D9E2E2880F7C Q36623007-70461FB8-4E33-465D-BDFA-11C88D6E42C7 Q36905034-889EB47D-4D6F-48A5-9302-97CBFB30D4C8 Q36912168-CF749892-813E-489C-837D-E3BDEEB839B6 Q36980709-A5188E53-42CF-4B7C-A7FA-15893EDADA38 Q36982759-7EB9F3EA-A657-4059-A29A-0AC981F23BEE Q36989404-4219C609-1DE4-4684-A148-9F3E4DB0F0B5 Q36989406-5497CF78-C314-4C14-A000-4225775F327E Q37000055-66F0AE93-17A0-4C91-B76B-250E071D9AEC Q37033656-2315A962-FFC6-4978-8A86-E7633E47D719 Q37149283-72588A33-F18B-4F36-98C3-1F7E62E8240E Q37215444-66DCCD51-A640-46D7-AD0C-C49EEA091016 Q37388460-174D0BF9-DA89-4FAB-8670-4E36AB318916 Q37426491-4AAFAC38-B97E-440E-8FD5-7681529849AC Q37451537-AC478124-AB16-4C94-B2AB-142FA7A0267A Q37499002-C4C409E5-243C-4E20-B825-835FDAF3D058 Q37499919-3B8E24C1-D7E5-40BB-9A2A-0610F3C7F9FC Q37505881-4C95D5F7-66E5-44A2-A5F7-DAF6E017AAC6

P2860

Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis

http://www.wikidata.org/entity/Q24545775

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Re-examining the efficacy of b ...... hypertension: a meta-analysis

@ast

Re-examining the efficacy of b ...... hypertension: a meta-analysis

@en

Re-examining the efficacy of b ...... hypertension: a meta-analysis

@nl

type

label

Re-examining the efficacy of b ...... hypertension: a meta-analysis

@ast

Re-examining the efficacy of b ...... hypertension: a meta-analysis

@en

Re-examining the efficacy of b ...... hypertension: a meta-analysis

@nl

prefLabel

Re-examining the efficacy of b ...... hypertension: a meta-analysis

@ast

Re-examining the efficacy of b ...... hypertension: a meta-analysis

@en

Re-examining the efficacy of b ...... hypertension: a meta-analysis

@nl

P1433

Q24545775-B5A53E8E-462E-4D4C-AFBD-9E9D7C8CC6FB

P1476

Q24545775-986F3418-9842-468B-8C8D-E3057BCCBFD0

P2093

Q24545775-6415B507-2DA4-4F20-8A4B-A28B5683B688

Q24545775-B5B0FE1D-1BAB-4437-AC03-F6B19B16C64C

P2860

Q24545775-0397E73B-FF11-4612-AE14-09D1BBA02B44

Q24545775-12D28974-4ECA-4B77-B70F-1CAA41F89961

Q24545775-1D049C33-83E5-48AA-9864-A2368D2BBD41

Q24545775-3B32DB60-6FFB-4247-9063-D694D185CD8C

Q24545775-4FE3CA38-5413-48D5-AF9B-849510D20098

Q24545775-67C00A26-F28F-467E-B8E0-B6F9FA155CCC

Q24545775-704AEEC2-9F7C-4F08-91A2-7DD3BFE6AA16

Q24545775-79793B83-5D2B-4A84-84A4-5C0C64379FE3

Q24545775-7F0F10C4-32A9-4CFD-B02C-B0585366832D

Q24545775-9D628BFF-912F-4941-B37E-FF1B8CC6F287

P304

Q24545775-E2994FA5-05F8-4AA0-963F-3E17DBA47993

P31

Q24545775-411E9DA2-9E88-4690-A6E6-7A42C9623DF2

Q24545775-FB8B6B20-34EE-4D2D-8D9C-E84BF669BD7D

P3181

Q24545775-0F98830D-F0E9-4DA9-8037-FC3C8C1A580D

P356

Q24545775-D61CBF42-B30D-48F5-B78A-4D0F4FCEFFD6

P407

Q24545775-2D31CC52-33AB-4BFA-87A4-0F0446B56F35

P433

Q24545775-1F133133-BAD3-496E-BB6D-7A1928494E85

P478

Q24545775-564847F2-8452-4B50-8D95-F0E9780E6EDF

P577

Q24545775-203FE2D1-7FED-4814-8A23-C4187F9FC234

P5875

Q24545775-B60322A8-E337-4CF8-9655-06DE1EBE28A9

P698

Q24545775-F6C2E9FE-BAA3-4EBD-8AF9-CE56E857C5D1

P921

Q24545775-6A993352-2A77-43E1-8C11-AC6AF8FBA9EE

Q24545775-D2B19B30-B860-4E15-AF83-D92F73570A2E

P932

Q24545775-A244A61C-3B35-4059-9831-025E92F2DF6C

P3181

P356

P1433

Canadian Medical Association Journal

P1476

Re-examining the efficacy of b ...... hypertension: a meta-analysis

@en

P2093

Finlay A McAlister

http://www.w3.org/2001/XMLSchema#string

Nadia Khan

http://www.w3.org/2001/XMLSchema#string

P2860

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

Blood pressure, stroke, and coronary heart disease

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Randomised trial of treatment of hypertension in elderly patients in primary care.

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications.

P304

1737-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3154709

http://www.w3.org/2001/XMLSchema#string

P356

10.1503/CMAJ.060110

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7027932

http://www.w3.org/2001/XMLSchema#string

P698

16754904

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

1471831

http://www.w3.org/2001/XMLSchema#string